China Guidelines on Pricing Conduct by Business Operators for Drugs in Shortage and Active Pharmaceutical Ingredients

1 articles available

Adrian Emch, Hogan Lovells

China Proposes New Rules to Address Perceived Anti-Competitive Practices in the Pharmaceutical Industry

August 18, 2017

On 14 August 2017, the National Development and Reform Commission (“NDRC“) released a draft of the Guidelines on Pricing Conduct by Business Operators for Drugs in Shortage and Active Pharmaceutical…

Popular tags